Edward Kerslake is an accomplished leader in commercial and residential real estate development and healthcare, serving as President of Spencer Land Management since 2002. Kerslake holds advisory and board positions in several innovative medical companies, including Tal Medical Inc., Allurion Technologies, and GI Scientific. Previously, Kerslake held the role of CEO at Topera, where a significant acquisition by Abbott Labs occurred, and served as Corporate Vice President at Boston Scientific, overseeing corporate portfolio management. Kerslake's extensive background also includes leadership roles in healthcare IT at MDdatacor and strategic consultancy at The Monitor Group. Educational credentials include a Ph.D. in Pharmaceutical Sciences from Cardiff University and an MBA in Healthcare from UC Irvine.